top of page
News
Titans for PBM Reform: Loretta Boesing & Antonio Ciaccia | PBM Reform
House Energy and Commerce Committee cleared a PBM bill that seems to contain more transparency loopholes and makes more limited policy...
Jun 15, 2023
Marshall, Menendez, Blackburn, Wyden, Crapo, & Tester Introduce Bipartisan Legislation to Reform PBM
Today, U.S. Senator Roger Marshall (R-KS) joined Senators Bob Menendez (D-NJ) and Marsha Blackburn (R-TN), Senate Finance Chairman Ron...
Jun 15, 2023
FTC Further Expands Inquiry Into Prescription Drug Middlemen Industry Practices
Agency issues order to additional GPO as it examines the impact of vertically integrated PBMs on prescription drug prices and access As...
Jun 8, 2023
US Officials Probe a New Layer in Opaque Drug Pricing, Supply System
US authorities are looking into new groups that were formed to negotiate drug discounts but may actually be further obscuring how much...
May 23, 2023
The Top Pharmacy Benefit Managers of 2022: Market Share and Trends for the Biggest Companies
In 2022, the PBM market remained highly consolidated—although there were some intriguing share shifts among the largest players. Below,...
May 23, 2023
The Mysteries of Making Savings a Reality at the Pharmacy Counter
One way or another, it looks like the drug supply chain middlemen known as pharmacy benefit managers, or PBMs, are going to be pulled out...
May 17, 2023
PBGH: What employers want to see as Congress aims to reform PBMs
A key Senate committee last week advanced a bill that includes a number of significant reforms to pharmacy benefit managers, including a...
May 16, 2023
Report: “Specialty” drugs are by far the most expensive, but classification seems arbitrary
The prescriptions with the most eye-popping price tags — like cancer meds that can cost more than $20,000 a month — are usually...
May 15, 2023
PBMs, the Brokers Who Control Drug Prices, Finally Get Washington’s Attention
For two decades, patients and physicians eagerly awaited a lower-cost version of the world’s bestselling drug, Humira, while its maker,...
May 12, 2023
Senate panel advances bill that would ban spread pricing
Despite pushback from Republicans, a key Senate committee has advanced a bill that aims to reform pharmacy benefit managers, including a...
May 11, 2023
PBM Accountability Project Statement on H.R. 2880
The Protecting Patients Against PBM Abuses Act will bring meaningful reforms to help lower out-of-pocket costs for prescription drugs...
May 10, 2023
PBM Accountability Project and More Than 40 Stakeholder Organizations Urge Meaningful Action on PBMs
Leading Patient, Provider, Pharmacy, Labor, Anti-Monopoly and Employer Groups Seek Congressional Reforms to Require PBM Transparency,...
May 3, 2023
Commerce fines CVS Caremark $500,000 after 2022 case alleging violations of Pharmacy Benefit Manager
The Minnesota Department of Commerce today announced it has levied a $500,000 penalty against Caremark after alleging that Caremark...
May 1, 2023
PBM Accountability Project Statement on House Subcommittee Hearing to Lower Healthcare Costs
The House Energy and Commerce Committee Subcommittee on Health this week held a legislative hearing entitled, “Lowering Unaffordable...
Apr 27, 2023
Statement on Senate Finance Committee Proposed Bipartisan Policy Solutions
The Senate Finance Committee announced a set of proposed policy solutions to address challenges in the prescription drug supply chain,...
Apr 20, 2023
Iowa Leads in cracking down on PBMs
From the early days of the caucuses through the general election, Iowans make a point to ask tough questions that highlight the...
Apr 17, 2023
Oregonians Strongly Support Legislative Policies to Require PBMs to Lower Drug Costs, Provide Value
New Poll Finds 87% of Respondents Support Regulating Pharmacy Benefit Managers Salem, Ore. – With the Beaver State already facing...
Apr 14, 2023
Video: Congressional Hearings Put PBMs in Spotlight
Several Congressional Committees recently have held hearings where criticism of harmful PBM business practices has taken center stage....
Apr 10, 2023
Johnson, Spanberger Introduce Bipartisan Bill to Protect 340B Program, Prevent Higher Drug Prices
Today, U.S. Representatives Dusty Johnson (R-S.D.) and Abigail Spanberger (D-VA-07) introduced a bipartisan bill that would prohibit...
Apr 7, 2023
‘True disruption’: Mark Cuban’s company will sell brand-name diabetes medicines from J&J
For the first time, Mark Cuban’s Cost Plus Drug Company is selling medicines made by a large drug manufacturer directly to consumers at a...
Apr 4, 2023
Podcast: Spotting Anticompetitive Conduct in Pharma Supply Chain, with Antonio Ciaccia
46brooklyn is a group of pharmacy experts who set out to educate others about what they had learned about the frustrating complexity of...
Apr 4, 2023
Video: PBMs Face Criticism at Recent Hearing
The Senate Finance Committee held a hearing on March 30 to discuss how pharmacy benefit managers (PBMs) affect patients and taxpayers....
Apr 4, 2023
PBMs Are Again In The Crosshairs Of Congress & The FTC: Action To Reform Drug Pricing Increasingly
The pressure on pharmacy benefit managers (PBMs) is ramping up. Both Congress and the Federal Trade Commission (FTC) are probing alleged...
Apr 2, 2023
Senate Finance Committee lobs more bipartisan pressure onto PBMs
Congress is honing in on how it wants to overhaul the rules of the road for pharmacy benefit managers, with a Senate Finance Committee...
Mar 31, 2023
bottom of page
